摘要:
The invention relates to a cosmetic foam made from a) an emulsion containing glyceryl stearate citrate and b) a gas or gas mixture made from propane, n-butane and/or isobutane, foaming the emulsion. Said emulsion does not contain polyethylene glycol derivatives (PEG derivatives).
摘要:
The invention relates to the use of a siloxane elastomer, which is swollen in a solvent, in cosmetic preparations in order to increase the water-resistance of said preparations. Said gel: I) is produced by reacting (A) an ≡Si-H-containing polysiloxane of formula R 3 SiO(R' 2 SiO) a (R''HSiO) b SiR 3 and optionally an ≡Si-H-containing polysiloxane of formula HR 2 SiO(R' 2 SiO) c SiR 2 H or formula HR 2 SiO(R' 2 SiO) a (R''HSiO) b SiR 2 H, where R, R' and R'' = alkyl groups comprising 1 to 6 C atoms, a = 0-250, b = 1-250, and c = 0-250, (B) with an alpha, omega diene of formula CH 2 =CH(CH 2 ) x CH=CH 2 , where x = 1-20, said reaction being carried out in the presence of a platinum catalyst and (C) a solvent selected from the group consisting of (i) organic components, (ii) components containing a silicone atom and any mixtures thereof and being carried out until a gel is achieved by cross-linking by the addition of ≡Si-H to the double bonds of the alpha, omega diene, or; II) has the following structure (AA) where R 1 = a C 1 to C 30 alkyl group, R 2 = hydrogen, R 3 = a cross-link -E-Y-E-, in which the other end of the cross-link is connected to a second silicone elastomer chain, each E represents a divalent group selected from the groups -CH 2 -CH 2 - or -CH=CH- and Y represents a divalent hydrocarbon group, a siloxane or a combination of the two, a = 265-2,000, b = 0-249 and C = 1-250, with the proviso that b+c ≤ 250.
摘要:
The invention relates to a cosmetic preparation containing a) cetearyl sulfosuccinates, b) 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene), and c) 4-(tert.-butyl)-4'-methoxydibenzoylmethane.
摘要:
The invention relates to a cosmetic preparation which contains a combination of a) 2,4,6-tris-(biphenyl)-,3,5-triazine, b) phenylbenzimidazole sulfonic acid and/or the salts thereof, c) 2-(4'-diethylamino-2'-hydoxybenzoyl)-benzoic acid hexyl ester.
摘要:
The invention relates to a cosmetic composition comprising a) sodium stearyl glutamate, b) a crosslinked polymer of vinylpyrrolidone and acrylic acid.
摘要:
Cosmetic sunscreen agents contain a) from 20 to 90 wt. % ethanol, b) from 10 to 45 wt. %, at 20 °C, aqueous oil components, c) from 1,0 to 12 wt. % UV-A-protective light filter from the group of compounds 2-(4'-diethylamino-2'-hydoxybenzoyl)-benzoic acid hexylester, 2,4-to-[5-1(dimethyl-propyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine, 4-(tert.-butyl)-4'- methoxydibenzoylmethane. The concentration indications relate to the total weight of the preparation.
摘要:
Kosmetische Zubereitung enthaltend a) ein oder mehrere UV-Filter aus der Gruppe der Triazinderivate, b) Titandioxid, c) 2-(4'-(Diethylamino)-2'-hydoxybenzoyl)-benzoesäurehexylester, d) 2-Phenylbenzimidazol-5-sulfonsäure und/oder deren Salze, e) ein oder mehrere Öle gewählt aus der Gruppe der Verbindungen Butylene Glycol Dicaprylat/Dicaprat, Phenethyl Benzoat, C12-15 Alkyl Benzoat, Dibutyladipat; Diisopropylbenzoate, Di-C12-13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydragenated Castor Oil Dimerate, Triheptanoin, C12-13 Alkyl Lactate, C16-17 Alkyl Benzoate, Propylheptyl Caprylate, Caprylic/Capric Triglyceride, Diethylhexyl 2,6-Naphthalate, Octyldodecanol, Caprylic/Capric Triglyceride, Ethylhexyl Cocoate, wobei die Zubereitung frei ist von Ethylhexylsalicylat, 2-Ethylhexyl-2-cyano-3,3-di-phenylacrylat, Homomenthylsalicylat, 4-Methoxyzimtsäure(2-ethylhexyl)ester und 3-(4-Methylbenzyliden)campher, dadurch gekennzeichnet, dass die Zubereitung Ethanol enthält.
摘要:
The invention relates to preparations, in particular cosmetic or dermatological preparations, containing a) at least 0.5 wt.%, preferably at least 2 wt.%, of ascorbic acid and/or ascorbyl compounds relative to the total weight of the preparations, b) one or more water-soluble phosphates, in particular orthophosphates, c) 4-tert-butyl-4'-methoxydibenzoylmethane, and d) ubidecarenone (coenzyme Q10).